When it comes to cancer, tumor suppressor genes are usually thought of as the "good guys." These genes make proteins that ...
A Phase I clinical trial is testing whether a tumor-targeting virus can help immunotherapy work more effectively against ...
After years of advocating for a better coding system, ACOG said the AMA is replacing bundled global obstetric CPT codes ...
Foundation Medicine, Inc., a global, patient-focused precision medicine company, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®CDx to ...
Training deficits in STS brachytherapy stem primarily from limited resident case exposure, despite broad perceived importance ...
Datopotamab deruxtecan is now a first-line targeted therapy for immunotherapy-ineligible metastatic TNBC, addressing the ~70% ...
Semaglutide for reducing the risk of major adverse cardiovascular events in people with cardiovascular disease and overweight or obesity TA1152 7 May 2026 7 May 2026 Zanidatamab for treating ...
Haematological malignancies are the types of cancer affecting blood, bone marrow and lymph nodes. They are referred to as leukaemia, lymphoma and myeloma depending on the type of cell affected. The ...
This study explores the clonal architecture of aplastic anemia across age using single-cell approaches. Somatic inactivation of specific human leukocyte antigen risk alleles is a frequent event and ...
A major focus of the guideline is earlier intervention through healthy lifestyle changes, starting in childhood. Early consideration of pharmacotherapy in youth with familial hypercholesterolemia (FH) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results